candesartan has been researched along with Hypovolemia in 3 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Hypovolemia: An abnormally low volume of blood circulating through the body. It may result in hypovolemic shock (see SHOCK).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Angiotensin II (AngII) is an important vasoconstrictor during hypovolemia." | 7.70 | Angiotensin II blockade in existing hypovolemia: effects of candesartan in the porcine splanchnic and renal circulation. ( Aneman, A; Ewert, S; Fändriks, L; Laesser, M; Pettersson, A, 2000) |
| "Acute, graded hypovolemia by 20% and 40% of the total estimated blood volume followed by retransfusion in control animals (CTRL; n = 10) and animals pretreated with the AT1 receptor blocker candesartan (CAND; n = 10)." | 3.70 | Specific angiotensin II receptor blockage improves intestinal perfusion during graded hypovolemia in pigs. ( Aneman, A; Biber, B; Broomé, M; Fändriks, L; Petterson, A; Svensson, M, 2000) |
| "Angiotensin II (AngII) is an important vasoconstrictor during hypovolemia." | 3.70 | Angiotensin II blockade in existing hypovolemia: effects of candesartan in the porcine splanchnic and renal circulation. ( Aneman, A; Ewert, S; Fändriks, L; Laesser, M; Pettersson, A, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Laesser, M | 2 |
| Spak, E | 1 |
| Ewert, S | 2 |
| Aneman, A | 3 |
| Fandriks, L | 3 |
| Svensson, M | 1 |
| Broomé, M | 1 |
| Biber, B | 1 |
| Petterson, A | 1 |
| Pettersson, A | 1 |
3 other studies available for candesartan and Hypovolemia
| Article | Year |
|---|---|
Candesartan improves survival following severe hypovolemia in pigs; a role for the angiotensin II type 2 receptor?
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Benzimida | 2005 |
Specific angiotensin II receptor blockage improves intestinal perfusion during graded hypovolemia in pigs.
Topics: Acid-Base Equilibrium; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds | 2000 |
Angiotensin II blockade in existing hypovolemia: effects of candesartan in the porcine splanchnic and renal circulation.
Topics: Acid-Base Equilibrium; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Bi | 2000 |